Net Cash Provided by (Used in) Operating Activities |
-15.3M |
USD |
+74% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
40.7M |
USD |
+46% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
25.4M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
152M |
USD |
+27.6% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
723K |
USD |
-19.8% |
Q3 2024 |
Q3 2024 |
Deferred Income Tax Expense (Benefit) |
1.54M |
USD |
-75.9% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.22M |
USD |
-14.1% |
Q3 2024 |
Q3 2024 |
Deferred Federal Income Tax Expense (Benefit) |
512K |
USD |
|
Q1 2022 |
Q1 2022 |
Current Income Tax Expense (Benefit) |
10K |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
995M |
USD |
+23.3% |
Q3 2024 |
Q3 2024 |
Current State and Local Tax Expense (Benefit) |
-44K |
USD |
|
Q1 2022 |
Q1 2022 |
Current Federal Tax Expense (Benefit) |
-174K |
USD |
|
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
801K |
USD |
-31% |
Q3 2024 |
Q3 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
184K |
USD |
|
Q1 2022 |
Q1 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |